120 related articles for article (PubMed ID: 12115540)
1. RPR-115135, a farnesyltransferase inhibitor, increases 5-FU- cytotoxicity in ten human colon cancer cell lines: role of p53.
Russo P; Malacarne D; Falugi C; Trombino S; O'Connor PM
Int J Cancer; 2002 Jul; 100(3):266-75. PubMed ID: 12115540
[TBL] [Abstract][Full Text] [Related]
2. Nonpeptidomimetic farnesyltransferase inhibitor RPR-115135 increases cytotoxicity of 5-fluorouracil: role of p53.
Russo P; Ottoboni C; Malacarne D; Crippa A; Riou JF; O'Connor PM
J Pharmacol Exp Ther; 2002 Jan; 300(1):220-6. PubMed ID: 11752120
[TBL] [Abstract][Full Text] [Related]
3. RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G0/G1 arrest only in serum starved cells.
Russo P; Ottoboni C; Crippa A; Riou JF; O'Connor PM
Int J Oncol; 2001 Apr; 18(4):855-62. PubMed ID: 11251185
[TBL] [Abstract][Full Text] [Related]
4. c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor.
Russo P; Arzani D; Trombino S; Falugi C
J Pharmacol Exp Ther; 2003 Jan; 304(1):37-47. PubMed ID: 12490573
[TBL] [Abstract][Full Text] [Related]
5. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
6. Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates.
Backus HH; Pinedo HM; Wouters D; Kuiper CM; Jansen G; van Groeningen CJ; Peters GJ
Oncol Res; 2000; 12(5):231-9. PubMed ID: 11417748
[TBL] [Abstract][Full Text] [Related]
7. Induction of micronuclei by a new non-peptidic mimetic farnesyltransferase inhibitor RPR-115135: role of gene mutations.
Ottoboni C; Crippa A; Falugi C; Russo P
Mutagenesis; 2001 Sep; 16(5):423-30. PubMed ID: 11507242
[TBL] [Abstract][Full Text] [Related]
8. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration.
Choi JH; Yoon JS; Won YW; Park BB; Lee YY
APMIS; 2012 Jul; 120(7):597-604. PubMed ID: 22716215
[TBL] [Abstract][Full Text] [Related]
9. Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.
Chen XX; Lai MD; Zhang YL; Huang Q
World J Gastroenterol; 2002 Oct; 8(5):841-6. PubMed ID: 12378627
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of 5-fluorouracil on human colon cancer cell lines: antagonism by levamisole.
Wiebke EA; Grieshop NA; Loehrer PJ; Eckert GJ; Sidner RA
J Surg Res; 2003 May; 111(1):63-9. PubMed ID: 12842449
[TBL] [Abstract][Full Text] [Related]
11. Cellular effects of a new farnesyltransferase inhibitor, RPR-115135, in a human isogenic colon cancer cell line model system HCT-116.
Russo P; Ottoboni C; Falugi C; Reinhold W; Riou JF; Parodi S; O'Connor PM
Ann N Y Acad Sci; 1999; 886():252-6. PubMed ID: 10667232
[No Abstract] [Full Text] [Related]
12. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.
Violette S; Poulain L; Dussaulx E; Pepin D; Faussat AM; Chambaz J; Lacorte JM; Staedel C; Lesuffleur T
Int J Cancer; 2002 Apr; 98(4):498-504. PubMed ID: 11920608
[TBL] [Abstract][Full Text] [Related]
13. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil.
Calviello G; Di Nicuolo F; Serini S; Piccioni E; Boninsegna A; Maggiano N; Ranelletti FO; Palozza P
Cancer Chemother Pharmacol; 2005 Jan; 55(1):12-20. PubMed ID: 15365767
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
15. [Potentiation of 5-fluorouracil efficacy. Molecular mechanisms playing a role in the cytotoxic action of 5-fluorouracil and 5-ethyl-2'-deoxyuridine (EUdR) combination].
Katona C; Timár F; Oláh J; Bocsi J; Budai B; Otvös L; Kralovánszky J
Magy Onkol; 2004; 48(3):243-51. PubMed ID: 15520875
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.
Lim YJ; Rhee JC; Bae YM; Chun WJ
World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Feldkamp MM; Lau N; Guha A
Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
[TBL] [Abstract][Full Text] [Related]
19. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation.
Xavier CP; Lima CF; Rohde M; Pereira-Wilson C
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1449-57. PubMed ID: 21479885
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells.
Ju J; Schmitz JC; Song B; Kudo K; Chu E
Clin Cancer Res; 2007 Jul; 13(14):4245-51. PubMed ID: 17634554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
